Comparison of Three Different Puncture Techniques in EBUS-TBNA

November 24, 2022 updated by: Beijing Friendship Hospital
The purpose of this study was to compare the accuracy and sensitivity of slow-pull capillary technique, traditional suction aspiration and non negative pressure puncture in the diagnosis of mediastinal and/or hilar lymph node enlargement by ultrasound bronchoscopic lymph node biopsy.

Study Overview

Detailed Description

EBUS-TBNA has been widely used in the diagnosis of diseases involving lung hilar and mediastinal lymph node enlargement.But different puncture methods are still controversial. Research shows that there was no significant difference in sample adequacy, diagnostic specificity and accuracy between the no negative pressure aspiration and traditional negative pressure aspiration technique.Slow-pull capillary technique is a relatively new operating method of endoscopic ultrasound guided fine needle biopsy in recent years. At present, this technology is widely used in pancreatic space occupying lesions. Compared with the traditional negative pressure aspiration method, our previous retrospective study found that the slow-pull capillary technique can improve the diagnostic accuracy of patients. Therefore, the purpose of this study is to prospectively and randomly compare the advantages and disadvantages of three puncture methods in EBUS-TBNA.

Study Type

Interventional

Enrollment (Anticipated)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100050
        • Recruiting
        • Beijing Friendship Hospital, Capital Medical University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18-80years
  • Chest computed tomography showing hilar or mediastinal lymph node enlargement
  • No contraindications for bronchoscopy
  • Signed informed consent provided by the patient
  • Disease needs to be diagnosed through the EBUS-TBNA

Exclusion Criteria:

  • Severe coagulation dysfunction
  • Severe cardiopulmonary dysfunction
  • Acute asthma attack or massive haemoptysis
  • Poor general condition
  • Physical weakness without tolerance for anaesthesia or allergy to narcotic drug
  • Disease can be diagnosed by other less invasive methods (such as skin or peripheral superficial lymph node biopsy)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: EBUS-TBNSP
The slow-pull capillary technique was performed as follows: after identification and measurement of the target lymph node, a needle was used to puncture the lymph node with the stylet in place.At the same time, the stylet was slowly and continuously pulled to create weak negative pressure.
The slow-pull capillary technique was performed as follows: after identification and measurement of the target lymph node, a needle was used to puncture the lymph node with the stylet in place.At the same time, the stylet was slowly and continuously pulled to create weak negative pressure.
Other Names:
  • Slow-pull capillary technique
Experimental: EBUS-TBNA
The operation steps are the same as above, but the negative pressure device of 10ml syringe is connected behind the puncture needle.
The operation steps are the same as above, but the negative pressure device of 10ml syringe is connected behind the puncture needle.
Other Names:
  • Standard suction
Experimental: EBUS-TBNCS
The operation steps are the same as above, but there is no negative pressure device behind the puncture needle
The operation steps are the same as above, but there is no negative pressure device behind the puncture needle
Other Names:
  • Fine needle sampling without suction

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnostic accuracy of three different puncture methods according to pathological diagnosis
Time Frame: 6 months
The final pathological diagnosis was based on all available cytological and histological samples. In cases with negative pathological results , we continue to follow up the patients for ⩾6months.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood contamination of samples
Time Frame: 1 week
Blood contamination was categorized as follows: low (no or few blood cells influencing the diagnosis), moderate (sample partially obscured by blood cells, but pathological diagnosis possible), and high (large numbers of blood cells, rendering pathological diagnosis difficult)
1 week
Bleeding of operation
Time Frame: 1 week
There are three levels of bleeding:Small amount of bleeding(Ⅰ): Bleeding can stop spontaneously without continuous suction.Moderate bleeding(Ⅱ): Continuous suction is required, and epinephrine or ice salt water is used locally to stop bleeding.Massive bleeding(Ⅲ): Patients who need to be used balloon compression, interventional treatment, or blood transfusion treatment or even died of asphyxia due to bleeding.
1 week
Acquisition of tissue core of three different puncture methods according to the judgment of the pathologist
Time Frame: 1 week
Tissue cores were immersed in formalin solution and subjected to histopathological examination. In the absence of a tissue core, the contents were pressed onto a glass slide, immersed in 96% methanol for ⩾10min and subjected to cytopathological examination.Some methods may only obtain cytological specimens, while others may obtain tissue cores. Tissue cores are better for pathologists to diagnose.
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yanjun Wu, Beijing Friendship Hospital
  • Study Director: Zhigang Yao, Beijing Friendship Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2022

Primary Completion (Anticipated)

November 1, 2024

Study Completion (Anticipated)

November 1, 2024

Study Registration Dates

First Submitted

November 6, 2022

First Submitted That Met QC Criteria

November 24, 2022

First Posted (Actual)

November 28, 2022

Study Record Updates

Last Update Posted (Actual)

November 28, 2022

Last Update Submitted That Met QC Criteria

November 24, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Cancer

Clinical Trials on Endobronchial ultrasound-guided transbronchial needle Slow-pull capillary sampling

3
Subscribe